牛奶蛋白-多结合物对GLP-1激素调节的作用
Huda Abdulrahim Wazzan1,2, Amanda N Abraham3, Noshin Saiara3
1Food and Nutrition, School of Human Science and Design, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Foods (Basel, Switzerland)
|June 27, 2024
概括
新的Apo-lactoferrin (Apo-LF) 和epigallocatechin gallate (EGCG) 的结合物通过促进结肠细胞中葡萄糖样-1 (GLP-1) 的分泌来增强腹感. 这些功能性食品成分还保留了EGCG的抗氧化功效.
科学领域:
- 食品科学与营养 食品科学与营养
- 生物化学 生物化学
- 细胞生物学 细胞生物学
背景情况:
- 功能性食品提供健康益处超出了基本营养,包括生物活性成分,如抗氧化剂.
- 已知牛奶蛋白 (乳酸) 和茶叶多 (EGCG) 影响和体重调节.
- 研究新的结合物可以提高生物活性化合物的稳定性和有效性.
研究的目的:
- 合成和表征与表甲基酸盐 (Apo-LF-EGCG) 结合的阿波-乳酸.
- 通过监测葡萄糖类-1 (GLP-1) 表达,评估Apo-LF-EGCG结合物的对度调节的影响.
- 评估结合对EGCG抗氧化特性和稳定性的影响.
主要方法:
- Apo-LF-EGCG结合物的合成和表征.
- 在人类NCI-H716结肠细胞中使用qRT-PCR和ELISA评估GLP-1基因和蛋白质表达.
- 评估EGCG抗氧化特性和结合后的稳定性.
主要成果:
- 成功合成了Apo-LF-EGCG合物,通过键显示了蛋白质多相互作用.
- 结合剂显著上调GLP-1的基因和蛋白质表达水平.
- 结合防止EGCG降解,保持其抗氧化性质.
结论:
- Apo-LF-EGCG结合物通过增加人类结肠细胞中的GLP-1分泌来增强腹感.
- 结合物保持了EGCG的有益的抗氧化特性.
- 这些新的合物显示出作为食补充剂的承诺,以增强腹感.
相关概念视频
Hormonal Regulation
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
Hormonal Regulation
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...
Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...


